vimarsana.com

Latest Breaking News On - Medical oncology meeting - Page 1 : vimarsana.com

Merck (MRK) Q3 2023 Earnings Call Transcript

MRK earnings call for the period ending September 30, 2023.

United statesLouise chen cantor fitzgeraldChris schottCaroline litchfieldAndrew baum citiMara goldsteinJonathan cohenHelen hobbsGeoff meachamSteve scalaAmerica merrill lynchChris shibutani goldman sachsMohit bansalTerence flynnAndrew baumSeamus fernandez

Johnson & Johnson (JNJ) Q3 2023 Earnings Call Transcript

JNJ earnings call for the period ending September 30, 2023.

New jerseyUnited statesSan diegoLouise chenMatt miksic barclaysChris shibutaniJessica mooreTecnis eyehanceLarry biegelsenChris shibutani goldman sachsAhmet tezelMatt miksicTerence flynn morgan stanleyJosh jenningsChris schott jpmorganJoaquin duato

Merck & Co (MRK) Q3 2022 Earnings Call Transcript

MRK earnings call for the period ending September 30, 2022.

Hong kongUnited kingdomLuisa hectorDaina grayboschChris shibutaniLuisa hector berenbergRob davisPeter dannenbaumCaroline litchfieldSteve scala cowenSteve scalaSeamus fernandez guggenheimMara goldsteinChris schott jpmorganMara goldstein mizuhoSeamus fernandez

GenFleet Therapeutics to Present Data from Phase I Trial of GFH018 Monotherapy at the 2022 European Society for Medical Oncology Annual Meeting

/PRNewswire/ GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, today announced.

France generalYu wangUnited statesYun zengEuropean society for medical oncology meetingFleet therapeuticsMedical oncology meetingProfessor ye guoShanghai orientalChief medical officerPoster areaGenfleet therapeuticsHealth care amp hospitalsMedical pharmaceuticalsClinical trials amp medical discoveriesTrade show news

DGX Boosts FY22 Outlook, NURO On Watch, PSTV To Present ReSPECT-GBM Data In Sep

WASHINGTON (dpa-AFX) - The following are some of the companies that reported second-quarter financial results and provided a pipeline update on Thursday.1. Quest Diagnostics Boosts FY22 OutlookQuest

United statesHoldings incThomson reutersEuropean society of medical oncology meetingQuest diagnostics incNeurometrix incIntuitive surgical incTherapeutics incDanaher corpDiagnostics boostsRevenue missMetrix quell to transitionQuell fibromyalgiaTherapeutics to present full data updateEuropean societyMedical oncology meeting

vimarsana © 2020. All Rights Reserved.